Chad Zender
Overview
Explore the profile of Chad Zender including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
588
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Badhey A, Pichardo P, Kavoosi T, Cervenka B, Silverman D, Tang A, et al.
Head Neck
. 2025 Mar;
PMID: 40045868
Background: This study demonstrates the role of the deltoid branch artery as a donor vessel for microvascular reconstruction in various free flaps in the vessel-depleted neck. Methods: This is a...
2.
Patil Y, Yakoub M, Moreno K, Cotton C, Tabangin M, Altaye M, et al.
Laryngoscope Investig Otolaryngol
. 2024 Feb;
9(1):e1215.
PMID: 38362201
Objective: To examine if perioperative blood transfusion affects overall survival (OS) and recurrence-free survival (RFS) in head and neck cancer patients who undergo free tissue reconstruction. Design: Retrospective cohort study....
3.
Bedard M, Chihanga T, Carlile A, Jackson R, Brusadelli M, Lee D, et al.
Nat Commun
. 2023 Apr;
14(1):1975.
PMID: 37031202
Persistent HPV16 infection is a major cause of the global cancer burden. The viral life cycle is dependent on the differentiation program of stratified squamous epithelium, but the landscape of...
4.
Leddon J, Gulati S, Haque S, Allen C, Palackdharry S, Mathews M, et al.
Clin Cancer Res
. 2022 Jun;
28(16):3464-3472.
PMID: 35653116
Purpose: Locoregional relapse in patients with head and neck squamous cell carcinoma (HNSCC) is common, approaching 50% for some subsites despite multimodality therapy. Salvage surgery is the standard of care,...
5.
Wise-Draper T, Gulati S, Palackdharry S, Hinrichs B, Worden F, Old M, et al.
Clin Cancer Res
. 2022 Mar;
28(7):1345-1352.
PMID: 35338369
Purpose: Patients with resected, local-regionally advanced, head and neck squamous cell carcinoma (HNSCC) have a one-year disease-free survival (DFS) rate of 65%-69% despite adjuvant (chemo)radiotherapy. Neoadjuvant PD-1 immune-checkpoint blockade (ICB)...
6.
Luginbuhl A, Calder A, Kutler D, Zender C, Wise-Draper T, Patel J, et al.
Front Oncol
. 2021 Dec;
11:786216.
PMID: 34900741
Introduction: Surgery is the primary treatment for resectable, non-metastatic recurrent head and neck squamous cell carcinoma (HNSCC). We explore the safety and oncologic benefit of intraoperative Cesium-131 (Cs-131) brachytherapy combined...
7.
von Allmen D, Tang A, Takiar V, Zender C, Romeo S, Masch J, et al.
Laryngoscope
. 2021 Apr;
131(11):2478-2482.
PMID: 33894000
Objectives/hypothesis: Dysphagia is a treatment-related complication of head and neck cancer (HNCA). We demonstrate the predictive value of a modified head and neck swallow scale (m-HNSW) adapted from the European...
8.
Kharouta M, Zender C, Podder T, Rezaee R, Lavertu P, Fowler N, et al.
Front Oncol
. 2021 Apr;
11:639480.
PMID: 33816283
Purpose/objectives: To establish the feasibility and safety of intraoperative placement of cesium-131 (Cs-131) seeds for re-irradiation in recurrent head and neck cancer (HNC). Methods: Patients with resectable recurrent HNC who...
9.
Sagheer S, Bornstein J, Bar-Ad V, Cheng M, Cummins A, Cognetti D, et al.
Laryngoscope
. 2021 Mar;
131(8):E2449-E2451.
PMID: 33729580
No abstract available.
10.
Luginbuhl A, Kahue C, Stewart M, Curry J, Weed D, Zender C, et al.
Head Neck
. 2021 Feb;
43(6):1780-1787.
PMID: 33586258
Background: Head and neck surgical oncology and reconstruction are uniquely suited to address burdens of disease in underserved areas. Since these efforts are not well known in our specialty, we...